哈药股份(600664.SH)：第三季度净利润6888.93万元，同比下降58.22%

Core Viewpoint - Harbin Pharmaceutical Group Co., Ltd. reported a decline in both revenue and net profit for the third quarter, indicating potential challenges in its financial performance [1] Financial Performance - The company achieved a revenue of 3.897 billion yuan in the third quarter, representing a year-on-year decrease of 5.29% [1] - The net profit attributable to shareholders was 68.8893 million yuan, down 58.22% year-on-year [1] - The net profit after deducting non-recurring gains and losses was 44.7083 million yuan, reflecting a significant decline of 71.75% year-on-year [1] - Basic earnings per share were reported at 0.03 yuan [1]